EVP& CBO, Ipsen
Corporate SVP, Global Head of BD&L, Boehringer Ingelheim
VP,Head of S&E & Transactions, GSK
Executive Director, BD&L, S&E, Merck
VP, Venture Science, Eli Lilly
VP, Venture Science, Eli Lilly
Vice President, Venture Capital, Eli Lilly
Global Chief DE&I Officer, Regeneron
VP, Head of BD, Alnylam Pharmaceuticals
Coporate Development, Gingko Bioworks
VP, Head US Commercial, Kite, A Gilead Company
Director, Business Development, Oncology, Astellas Pharma
Sr. Director Global Partnering, Neurosciences & Rare Diseases, Ipsen
Executive Director, Head of BD&L USA, Boehringer Ingelheim
Managing Director, Boehringer Ingelheim Venture Fund USA
VP Head of Collaborate to Cure USA, Bayer
SVP, M&A, BridgeBio
Sr. Associate Director, Strategic Partnering BD&L, Boehringer Ingelheim
EVP & Head of Corporate Development, Biogen
SVP, BD and M&A, BeiGene USA
Global Head, Partnering & BD, Sanofi
SVP Business Development, BMS
Head of Bio Innovation Hub, Novo Nordisk
Head of Corporate Development, Tillotts Pharma
Senior Director, S&E Oncology, GSK
Global head Oncology BD, Servier Monde
SVP, Head of Business Development & Corporate Strategy, Moderna
Biotech Executive, Multiple Biotechs
CEO, LifeMine Therapeutics
CEO, Cerevance
CEO, Abliva
Chief Corporate Affairs Officer, Ovid Therapeutics
VP Corporate Development, Cerevance
President & Founder, OUTbio
CEO, Shorla Oncology
CEO, Coastar Therapeutics
CEO, Orange Grove Bio
Supervisor, Invention Development Unit, National Cancer Institute–NIH
Chief Business Development Officer & Chief Compliance and Legal Officer, Strata Oncology
Chairman, National Foundation
CEO Rejuvenate Bio
CEO, Hemab
CEO, Xontogeny
VP Commercial Strategy and Operations, Aldeyra Therapeutics
Founder, CEO, & Chief Possibilities Officer, JBK Associates International
SVP, Market Access, Gamida Cell
CEO, FibroFind
CFO, ORUM Therapeutics
Senior Business Editor, Genetic Engineering & Biotechnology News
COO, FibroFind
Healthcare Business Writer, The Boston Globe
Chief Commercial Officer, Roivant Life Sciences
Head of Strategy & partnerships, RenovoRx
CEO, siRNAgen
Health Reporter, USA Today
Managing Director, Perceptive Advisors
CEO-Partner, Flagship Pioneering
Partner, Pfizer Ventures & VP, Partnering Innovations, Pfizer
Managing Director, M Ventures
VP Venture Investment, J&J Innovation
Managing Director, Sanofi Ventures
Managing Partner, Forbion
General Partner, Canaan Partners
CBO, RTW Investments
Senior Partner, Flagship Pioneering
General Partner, Forbion
Partner, Head of Business Development, Apple Tree Partners
Managing Director, Life Sciences, Bain Capital
Principal, Sofinnova Investments
Director, Foresite Capital
Partner, 5AM Ventures
Principal, Atlas Venture Partners
Managing Partner, Graybella Capital
Managing Director, Vertex Ventures
Principal, venBio Partners
Partner, MPM BioImpact Capital
Venture Partner, Pathway Bioventures
Operating Partner, 3E Bioventures
Senior Managing Director, Blackstone Life Sciences
Managing Director, Back Bay Life Science Advisors
Partner, Foley Hoag
Member, Mintz
Partner, Morrison & Foerster
Partner, Fox Rothschild
Partner, RSM
Managing Director, Danforth Advisors
Chief Innovation Officer, Halloran Consulting
Partner, ZS
Strategic Advisor, NDA
Partner, Brown Rudnick
Partner, Brown Rudnick
Director, Healthcare M&A, Leerink Partners
EVP USA, Nucleus Networks
Chief Scientific & Medical Officer, NDA
Director of DEI, Mass Bio
Executive Vice President Business Development, Nucleus Networks
LSX is the Life Science eXecutive partnering community.
We connect biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.
contact | privacy policy | good conduct policy | anti-slavery policy | anti-money laundering & financial crime policy | diversity & inclusion policy | terms & conditions
© 2022 all rights reserved by LSX Ltd